These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 39105259)

  • 1. The fecal microbiota of patients with primary biliary cholangitis (PBC) causes PBC-like liver lesions in mice and exacerbates liver damage in a mouse model of PBC.
    Jiang H; Yu Y; Hu X; Du B; Shao Y; Wang F; Chen L; Yan R; Li L; Lv L
    Gut Microbes; 2024; 16(1):2383353. PubMed ID: 39105259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Analysis of Serum and Fecal Bile Acid Profiles and Interaction with Gut Microbiota in Primary Biliary Cholangitis.
    Chen W; Wei Y; Xiong A; Li Y; Guan H; Wang Q; Miao Q; Bian Z; Xiao X; Lian M; Zhang J; Li B; Cao Q; Fan Z; Zhang W; Qiu D; Fang J; Gershwin ME; Yang L; Tang R; Ma X
    Clin Rev Allergy Immunol; 2020 Feb; 58(1):25-38. PubMed ID: 30900136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-fat diet modulates bile acid composition and gut microbiota, affecting severe cholangitis and cirrhotic change in murine primary biliary cholangitis.
    Umemura M; Honda A; Yamashita M; Chida T; Noritake H; Yamamoto K; Honda T; Ichimura-Shimizu M; Tsuneyama K; Miyazaki T; Kurono N; Leung PSC; Gershwin ME; Suda T; Kawata K
    J Autoimmun; 2024 Sep; 148():103287. PubMed ID: 39033687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring Advanced Therapies for Primary Biliary Cholangitis: Insights from the Gut Microbiota-Bile Acid-Immunity Network.
    Guo Z; He K; Pang K; Yang D; Lyu C; Xu H; Wu D
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-chain fatty acid and fecal microbiota profiles are linked to fibrosis in primary biliary cholangitis.
    Lammert C; Shin A; Xu H; Hemmerich C; O'Connell TM; Chalasani N
    FEMS Microbiol Lett; 2021 Apr; 368(6):. PubMed ID: 33836051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota translocation promotes autoimmune cholangitis.
    Ma HD; Zhao ZB; Ma WT; Liu QZ; Gao CY; Li L; Wang J; Tsuneyama K; Liu B; Zhang W; Zhou Y; Gershwin ME; Lian ZX
    J Autoimmun; 2018 Dec; 95():47-57. PubMed ID: 30340822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota promotes macrophage M1 polarization in hepatic sinusoidal obstruction syndrome via regulating intestinal barrier function mediated by butyrate.
    Zhao S; Zhang H; Zhu H; Zhao T; Tu J; Yin X; Yang S; Zhang W; Zhang F; Zhang M; Xu B; Zhuge Y; Xiao J
    Gut Microbes; 2024; 16(1):2377567. PubMed ID: 39012957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut Microbiota-Derived Butyrate Induces Epigenetic and Metabolic Reprogramming in Myeloid-Derived Suppressor Cells to Alleviate Primary Biliary Cholangitis.
    Wang R; Li B; Huang B; Li Y; Liu Q; Lyu Z; Chen R; Qian Q; Liang X; Pu X; Wu Y; Chen Y; Miao Q; Wang Q; Lian M; Xiao X; Leung PSC; Gershwin ME; You Z; Ma X; Tang R
    Gastroenterology; 2024 Sep; 167(4):733-749.e3. PubMed ID: 38810839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effects of LRP6-CRISPR on prevention of alcohol-related liver injury surpassed fecal microbiota transplant in a rat model.
    Yu L; Wang L; Yi H; Wu X
    Gut Microbes; 2020 Jul; 11(4):1015-1029. PubMed ID: 32167008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatobiliary and pancreatic: Multi-donor fecal microbiota transplantation attenuated high-fat diet-induced hepatic steatosis in mice by remodeling the gut microbiota.
    Shou D; Luo Q; Tang W; Cao C; Huang H; Chen H; Zhou Y
    J Gastroenterol Hepatol; 2023 Dec; 38(12):2195-2205. PubMed ID: 37787118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice.
    Matsui M; Fukunishi S; Nakano T; Ueno T; Higuchi K; Asai A
    mBio; 2021 Aug; 12(4):e0115521. PubMed ID: 34225483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations and correlations of the gut microbiome, metabolism and immunity in patients with primary biliary cirrhosis.
    Lv LX; Fang DQ; Shi D; Chen DY; Yan R; Zhu YX; Chen YF; Shao L; Guo FF; Wu WR; Li A; Shi HY; Jiang XW; Jiang HY; Xiao YH; Zheng SS; Li LJ
    Environ Microbiol; 2016 Jul; 18(7):2272-86. PubMed ID: 27243236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatial heterogeneity of bacterial colonization across different gut segments following inter-species microbiota transplantation.
    Li N; Zuo B; Huang S; Zeng B; Han D; Li T; Liu T; Wu Z; Wei H; Zhao J; Wang J
    Microbiome; 2020 Nov; 8(1):161. PubMed ID: 33208178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal Microbiota Transplantation Donor and Dietary Fiber Intervention Collectively Contribute to Gut Health in a Mouse Model.
    Zhong Y; Cao J; Ma Y; Zhang Y; Liu J; Wang H
    Front Immunol; 2022; 13():842669. PubMed ID: 35185934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recipient microbiome-related features predicting metabolic improvement following fecal microbiota transplantation in adults with severe obesity and metabolic syndrome: a secondary analysis of a phase 2 clinical trial.
    Zhang Z; Mocanu V; Deehan EC; Hotte N; Zhu Y; Wei S; Kao DH; Karmali S; Birch DW; Walter J; Madsen KL
    Gut Microbes; 2024; 16(1):2345134. PubMed ID: 38685731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penthorum chinense Pursh. extract attenuates non-alcholic fatty liver disease by regulating gut microbiota and bile acid metabolism in mice.
    Li X; Zhao W; Xiao M; Yu L; Chen Q; Hu X; Zhao Y; Xiong L; Chen X; Wang X; Ba Y; Guo Q; Wu X
    J Ethnopharmacol; 2022 Aug; 294():115333. PubMed ID: 35500802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bile acids and intestinal microbiota in autoimmune cholestatic liver diseases.
    Li Y; Tang R; Leung PSC; Gershwin ME; Ma X
    Autoimmun Rev; 2017 Sep; 16(9):885-896. PubMed ID: 28698093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretin alleviates biliary and liver injury during late-stage primary biliary cholangitis via restoration of secretory processes.
    Kennedy L; Carpino G; Owen T; Ceci L; Kundu D; Meadows V; Kyritsi K; Franchitto A; Onori P; Isidan A; Zhang W; Ekser B; Alvaro D; Gaudio E; Gershwin ME; Francis H; Glaser S; Alpini G
    J Hepatol; 2023 Jan; 78(1):99-113. PubMed ID: 35987275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in microbiota and their metabolites are associated with beneficial effects of bile acid sequestrant on icteric primary biliary Cholangitis.
    Li B; Zhang J; Chen Y; Wang Q; Yan L; Wang R; Wei Y; You Z; Li Y; Miao Q; Xiao X; Lian M; Chen W; Qiu D; Fang J; Gershwin ME; Tang R; Ma X
    Gut Microbes; 2021; 13(1):1946366. PubMed ID: 34437819
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of Fecal Microbiota Transplantation on Gut Bacterial Bile Acid Metabolism in Humans.
    Bustamante JM; Dawson T; Loeffler C; Marfori Z; Marchesi JR; Mullish BH; Thompson CC; Crandall KA; Rahnavard A; Allegretti JR; Cummings BP
    Nutrients; 2022 Dec; 14(24):. PubMed ID: 36558359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.